Literature DB >> 2031628

Cognitive changes at high altitude in healthy climbers and in climbers developing acute mountain sickness.

M Regard1, T Landis, J Casey, M Maggiorini, P Bärtsch, O Oelz.   

Abstract

We report the cognitive functions of 17 non-acclimatized mountaineers who ascended from low lands to an altitude of 4,559 m in 24 h and were studied there within 6 h. We found that this rapid ascent to high altitude had small, but differential effects upon cognitive performance depending upon the later development of acute mountain sickness (AMS). Subjects who developed AMS within a 24-48-h stay at high altitude were mildly impaired in short term memory, but improved in conceptual tasks, while subjects who remained healthy had a better short term memory performance but no improvement in cognitive flexibility. Possible explanations for these unexpected effects of high altitude are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 2031628

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  10 in total

Review 1.  Neuropsychological functioning associated with high-altitude exposure.

Authors:  Javier Virués-Ortega; Gualberto Buela-Casal; Eduardo Garrido; Bernardino Alcázar
Journal:  Neuropsychol Rev       Date:  2004-12       Impact factor: 7.444

2.  Acetazolamide pre-treatment before ascending to high altitudes: when to start?

Authors:  Martin Burtscher; Hannes Gatterer; Martin Faulhaber; Johannes Burtscher
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Sleep deprivation under sustained hypoxia protects against oxidative stress.

Authors:  Lalini Ramanathan; Jerome M Siegel
Journal:  Free Radic Biol Med       Date:  2011-08-25       Impact factor: 7.376

4.  Resting arterial oxygen saturation and breathing frequency as predictors for acute mountain sickness development: a prospective cohort study.

Authors:  Martin Faulhaber; Maria Wille; Hannes Gatterer; Dieter Heinrich; Martin Burtscher
Journal:  Sleep Breath       Date:  2014-01-17       Impact factor: 2.816

Review 5.  Working in permanent hypoxia for fire protection-impact on health.

Authors:  Peter Angerer; Dennis Nowak
Journal:  Int Arch Occup Environ Health       Date:  2003-01-31       Impact factor: 3.015

6.  Are nocturnal breathing, sleep, and cognitive performance impaired at moderate altitude (1,630-2,590 m)?

Authors:  Tsogyal D Latshang; Christian M Lo Cascio; Anne-Christin Stöwhas; Mirjam Grimm; Katrin Stadelmann; Noemi Tesler; Peter Achermann; Reto Huber; Malcolm Kohler; Konrad E Bloch
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

7.  Improvements in sleep-disordered breathing during acclimatization to 3800 m and the impact on cognitive function.

Authors:  Shyleen Frost; Jeremy E Orr; Britney Oeung; Nikhil Puvvula; Kathy Pham; Rebbecca Brena; Pamela DeYoung; Sonia Jain; Shelly Sun; Atul Malhotra; Erica C Heinrich
Journal:  Physiol Rep       Date:  2021-05

8.  Impaired postural control in healthy men at moderate altitude (1630 m and 2590 m): data from a randomized trial.

Authors:  Katrin Stadelmann; Tsogyal D Latshang; Christian M Lo Cascio; Ross A Clark; Reto Huber; Malcolm Kohler; Peter Achermann; Konrad E Bloch
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

9.  AltitudeOmics: the integrative physiology of human acclimatization to hypobaric hypoxia and its retention upon reascent.

Authors:  Andrew W Subudhi; Nicolas Bourdillon; Jenna Bucher; Christopher Davis; Jonathan E Elliott; Morgan Eutermoster; Oghenero Evero; Jui-Lin Fan; Sonja Jameson-Van Houten; Colleen G Julian; Jonathan Kark; Sherri Kark; Bengt Kayser; Julia P Kern; See Eun Kim; Corinna Lathan; Steven S Laurie; Andrew T Lovering; Ryan Paterson; David M Polaner; Benjamin J Ryan; James L Spira; Jack W Tsao; Nadine B Wachsmuth; Robert C Roach
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  Principal Component Analysis and Risk Factors for Acute Mountain Sickness upon Acute Exposure at 3700 m.

Authors:  Shi-Zhu Bian; Jun Jin; Ji-Hang Zhang; Qian-Ning Li; Jie Yu; Shi-Yong Yu; Jian-Fei Chen; Xue-Jun Yu; Jun Qin; Lan Huang
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.